Abstract Background Although human respiratory syncytial virus (RSV) is an important cause of illness and death in older adults, no RSV vaccine has been licensed. Methods In a phase 2a study, we ra...
CITATION STYLE
Schmoele-Thoma, B., Zareba, A. M., Jiang, Q., Maddur, M. S., Danaf, R., Mann, A., … Swanson, K. A. (2022). Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study. New England Journal of Medicine, 386(25), 2377–2386. https://doi.org/10.1056/nejmoa2116154
Mendeley helps you to discover research relevant for your work.